X4 Pharmaceuticals Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About X4 Pharmaceuticals Inc.
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare diseases of the immune system. The Company’s lead clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy X4 Pharmaceuticals Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for X4 Pharmaceuticals Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for X4 Pharmaceuticals Inc. is XFOR:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
X4 Pharmaceuticals Inc. has its primary listing on NASDAQ. You can trade X4 Pharmaceuticals Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, X4 Pharmaceuticals Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include X4 Pharmaceuticals Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like X4 Pharmaceuticals Inc..